22.06.2010 • News

Symyx Rejects Certara Bid, Backs Accelrys Offer

Scientific research provider Symyx Technologies rejected a revised buyout proposal by Certara, saying it was not superior to an offer made by Accelrys Inc earlier this year.

On June 17, Certara, and its private equity sponsor Vector Capital, lowered its offer to acquire Symyx to $5.75 a share form its earlier proposal to buy the company for $6.75 a share.

In a statement on Monday, Symyx said Certara's revised proposal was inadequate when considered against the potential value of Symyx as a standalone company. Symyx said the proposal allowed Certara to revoke its proposal before Symyx shareholders could vote, or before the Accelrys agreement was terminated, putting Symyx at risk with potentially no transaction to consummate.

In April, Accelrys had offered to buy Symyx in a stock deal which valued Symyx at a little more than $5 a share, or about $175 million. After the merger, shareholders of each company would own about 50% of the combined entity. Symyx said it reaffirmed its commitment to a merger with Accelrys.

(06/22/2010)

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.